Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
This compound is handled strictly in pre-clinical settings and is distinct from the licensed pharmaceutical formulation Vyleesi
R., Santos, L
Noda Y, Izuno T, Tsuchiya Y, Hayasaka S, Matsumoto K, Murakami H, et al
An increased ratio of succinate to -KG in cancers resulting from impaired succinate dehydrogenase (SDH) activity is related to pervasive DNA hypermethylation, which contributes to the downregulation of key genes implicated in cell differentiation and cancer stages 102
Your regimen will be customized based on your results
US$ 25.78
US$ 20.39
US$ 20.33
US$ 24.74
US$ 22.06
